Alternative approaches for the application of ribozymes as gene therapies for retroviral infections.
Publication
, Journal Article
Campbell, TB; Sullenger, BA
Published in: Adv Pharmacol
1995
Duke Scholars
Published In
Adv Pharmacol
DOI
ISSN
1054-3589
Publication Date
1995
Volume
33
Start / End Page
143 / 178
Location
United States
Related Subject Headings
- Retroviridae Infections
- RNA, Catalytic
- HIV-1
- Genetic Therapy
- Gene Expression
- Biochemistry & Molecular Biology
- Animals
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Campbell, T. B., & Sullenger, B. A. (1995). Alternative approaches for the application of ribozymes as gene therapies for retroviral infections. Adv Pharmacol, 33, 143–178. https://doi.org/10.1016/s1054-3589(08)60668-7
Campbell, T. B., and B. A. Sullenger. “Alternative approaches for the application of ribozymes as gene therapies for retroviral infections.” Adv Pharmacol 33 (1995): 143–78. https://doi.org/10.1016/s1054-3589(08)60668-7.
Campbell TB, Sullenger BA. Alternative approaches for the application of ribozymes as gene therapies for retroviral infections. Adv Pharmacol. 1995;33:143–78.
Campbell, T. B., and B. A. Sullenger. “Alternative approaches for the application of ribozymes as gene therapies for retroviral infections.” Adv Pharmacol, vol. 33, 1995, pp. 143–78. Pubmed, doi:10.1016/s1054-3589(08)60668-7.
Campbell TB, Sullenger BA. Alternative approaches for the application of ribozymes as gene therapies for retroviral infections. Adv Pharmacol. 1995;33:143–178.
Published In
Adv Pharmacol
DOI
ISSN
1054-3589
Publication Date
1995
Volume
33
Start / End Page
143 / 178
Location
United States
Related Subject Headings
- Retroviridae Infections
- RNA, Catalytic
- HIV-1
- Genetic Therapy
- Gene Expression
- Biochemistry & Molecular Biology
- Animals
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences